PTTG1 and non-small cell lung carcinoma: In this context a predictive marker like PTTG-1 might be valuable to come to a decision on the still controversially discussed question if a patient with stage I-IIIA NSCLC should be treated with adjuvant chemotherapy or radiation after a histologically confirmed R0-resection of the tumor.